UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3259-3271

2013

Volltextzugriff (PDF)

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3406-3413

2017

Volltextzugriff (PDF)

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Journal of clinical oncology, 2005-12, Vol.23 (35), p.9008-9021

2005

Volltextzugriff (PDF)

Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation

Haematologica (Roma), 2012-06, Vol.97 (6), p.874-882

2012

Volltextzugriff (PDF)

Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance

Experimental dermatology, 2010-08, Vol.19 (8), p.760-771

2010

Volltextzugriff (PDF)

Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft‐versus‐host disease

Experimental dermatology, 2021-12, Vol.30 (12), p.1814-1819

2021

Volltextzugriff (PDF)

Intronic promoters and their noncoding transcripts: A new source of cancer-associated genes

Molecular carcinogenesis, 2014-02, Vol.53 (2), p.117-124

2014

Volltextzugriff (PDF)

Rapid identification and sorting of viable virus-reactive CD4 + and CD8 + T cells based on antigen-triggered CD137 expression

Journal of immunological methods, 2008-11, Vol.339 (1), p.23-37

2008

Volltextzugriff (PDF)

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3501-3501

2017

Volltextzugriff (PDF)

Rapid molecular dissection of viral and bacterial immunomes

European Journal of Immunology, 2006-04, Vol.36 (4), p.1049-1057

2006

Volltextzugriff (PDF)

Addressing tumour tolerance to improve cancer immunotherapy

European journal of immunology, 2010-12, Vol.40 (12), p.3302-3305

2010

Volltextzugriff (PDF)

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

British journal of haematology, 2015-03, Vol.168 (6), p.824-834

2015

Volltextzugriff (PDF)

Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell–engrafted NOD/SCID/IL-2Rγcnull mice

Experimental hematology, 2014, Vol.42 (1), p.28-38.e2

2014

Volltextzugriff (PDF)

Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines

Blood, 2007-01, Vol.109 (1), p.365-373

2007

Volltextzugriff (PDF)

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Blood, 2007-01, Vol.109 (1), p.374-382

2007

Volltextzugriff (PDF)

Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?

European journal of nuclear medicine and molecular imaging, 2009-03, Vol.36 (3), p.484-498

2009

Volltextzugriff (PDF)

Human epidermal Langerhans cells replenish skin xenografts and are depleted by alloreactive T cells in vivo

The Journal of immunology (1950), 2011-08, Vol.187 (3), p.1142-1149

2011

Volltextzugriff (PDF)

An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2007-10, Vol.58 (1), p.88-94

2007

Volltextzugriff (PDF)

The use of HLA-A0201-transfected K562 as standard antigen-presenting cells for CD8 + T lymphocytes in IFN-γ ELISPOT assays

Journal of immunological methods, 2002, Vol.259 (1), p.95-110

2002

Volltextzugriff (PDF)

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

Cancer Immunology, Immunotherapy, 2005-05, Vol.54 (5), p.453-467

2005

Volltextzugriff (PDF)

Sustained remissions and low rate of BCR‐ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: A 5‐year follow up

American journal of hematology, 2008-03, Vol.83 (3), p.178-184

2008

Volltextzugriff (PDF)

Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation

The Keio Journal of Medicine, 2003, Vol.52(3), pp.182-188

2003

Volltextzugriff (PDF)

Defense against Influenza A Virus Infection: Essential Role of the Chemokine System

Immunobiology (1979), 2001-12, Vol.204 (5), p.603-613

2001

Volltextzugriff (PDF)

Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein

The Journal of immunology (1950), 2005-02, Vol.174 (4), p.2404-2411

2005

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(193)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(103)
Humans
(83)
Male
(39)
Biological And Medical Sciences
(35)
Animals
(33)
Female
(33)
Physical Sciences
(30)
Adult
(25)
Immunology
(25)
Medical Sciences
(22)
Technology
(19)
Middle Aged
(18)
Mice
(17)
Aged
(15)
Physics
(15)
Biochemistry & Molecular Biology
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Molecular Sequence Data
(13)
Cardiac & Cardiovascular Systems
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse

Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation

Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance

Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft‐versus‐host disease

Intronic promoters and their noncoding transcripts: A new source of cancer-associated genes

Rapid identification and sorting of viable virus-reactive CD4 + and CD8 + T cells based on antigen-triggered CD137 expression

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Rapid molecular dissection of viral and bacterial immunomes

Addressing tumour tolerance to improve cancer immunotherapy

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell–engrafted NOD/SCID/IL-2Rγcnull mice

Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?

Human epidermal Langerhans cells replenish skin xenografts and are depleted by alloreactive T cells in vivo

An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer

The use of HLA-A0201-transfected K562 as standard antigen-presenting cells for CD8 + T lymphocytes in IFN-γ ELISPOT assays

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

Sustained remissions and low rate of BCR‐ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: A 5‐year follow up

Current results on the use of imatinib mesylate in patients with relapsed philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation

Defense against Influenza A Virus Infection: Essential Role of the Chemokine System

Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein

Suchergebnisse filtern